Valproate‐induced hepatic steatogenesis in rats

James H. Lewis, Hyman J. Zimmerman, Carlton T. Garrett, Elliot Rosenberg

Research output: Contribution to journalArticlepeer-review


The administration of high‐dose valproic acid (VPA) (750 mg per kg) consistently produced significant microvesicular steatosis in mature Sprague‐Dawley rats after 48 hr. Similar changes occurred in animals pretreated with phenobarbital which received a lower dose of VPA (350 mg per kg), but no steatosis was seen in animals treated with the low‐dose VPA alone. The steatogenic effect of VPA is most likely mediated by a toxic metabolite. It can also be speculated that phenobarbital, by enhancing the inducing effects of the hepatic mixed‐function oxidase system, may lead to increased conversion of VPA to a toxic metabolite. Young and weanling rats appeared to be resistant to the steatogenic effects of VPA. Reproduction of microvesicular steatosis in this experimental model may permit exploration of factors that enhance or inhibit VPA‐induced hepatic injury.

Original languageEnglish
Pages (from-to)870-873
Number of pages4
Issue number6
StatePublished - 1982
Externally publishedYes

ASJC Scopus subject areas

  • Hepatology


Dive into the research topics of 'Valproate‐induced hepatic steatogenesis in rats'. Together they form a unique fingerprint.

Cite this